药品注册申请号:202104
申请类型:ANDA (仿制药申请)
申请人:UPSHER SMITH LABS
申请人全名:UPSHER SMITH LABORATORIES LLC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 10MG No No None 2013/06/03 2013/06/03 Prescription
002 MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 20MG No No AB 2013/06/03 Prescription
003 MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 30MG No No AB 2013/06/03 Prescription
004 MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 50MG No No AB 2013/06/03 Prescription
005 MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 60MG No No AB 2013/06/03 Prescription
006 MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 80MG No No AB 2013/06/03 Prescription
007 MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 100MG No Yes AB 2013/06/03 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
审批日期提交号审批结论提交分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2013/06/03 ORIG-1(原始申请) Approval
>>>补充申请<<<
审批日期提交号审批结论补充类别或审批类型审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2025/10/09 SUPPL-24(补充) Approval Labeling-Medication Guide,Labeling-Package Insert STANDARD
2024/10/31 SUPPL-25(补充) Approval REMS - MODIFIED - D-N-A
2023/12/15 SUPPL-23(补充) Approval Labeling-Medication Guide,Labeling-Package Insert STANDARD
2021/12/15 SUPPL-18(补充) Approval Labeling-Medication Guide,Labeling-Package Insert,Labeling-Patient Package Insert STANDARD
2021/12/15 SUPPL-14(补充) Approval Labeling-Medication Guide,Labeling-Package Insert STANDARD
2021/12/15 SUPPL-13(补充) Approval Labeling-Package Insert,Labeling-Medication Guide STANDARD
2018/09/18 SUPPL-11(补充) Approval REMS - MODIFIED - D-N-A
2017/05/26 SUPPL-9(补充) Approval REMS-Modified
2016/09/30 SUPPL-7(补充) Approval REMS - MODIFIED - D-N-A
2016/04/20 SUPPL-6(补充) Approval REMS-Modified
2015/06/26 SUPPL-5(补充) Approval REMS-Modified
2014/08/19 SUPPL-4(补充) Approval REMS-Modified
2014/07/15 SUPPL-2(补充) Approval Labeling-Package Insert STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
>>>活性成分:MORPHINE SULFATE; 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL; 规格:20MG; 治疗等效代码:AB<<<
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
202104 002 ANDA MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 20MG Prescription No No AB 2013/06/03 UPSHER SMITH LABS
200411 001 ANDA MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 20MG Discontinued No No AB 2016/04/12 IMPAX LABS INC
>>>活性成分:MORPHINE SULFATE; 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL; 规格:30MG; 治疗等效代码:AB<<<
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
202104 003 ANDA MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 30MG Prescription No No AB 2013/06/03 UPSHER SMITH LABS
200411 002 ANDA MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 30MG Discontinued No No AB 2016/04/12 IMPAX LABS INC
>>>活性成分:MORPHINE SULFATE; 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL; 规格:50MG; 治疗等效代码:AB<<<
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
202104 004 ANDA MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 50MG Prescription No No AB 2013/06/03 UPSHER SMITH LABS
200411 003 ANDA MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 50MG Discontinued No No AB 2016/04/12 IMPAX LABS INC
>>>活性成分:MORPHINE SULFATE; 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL; 规格:60MG; 治疗等效代码:AB<<<
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
202104 005 ANDA MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 60MG Prescription No No AB 2013/06/03 UPSHER SMITH LABS
200411 004 ANDA MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 60MG Discontinued No No AB 2016/04/12 IMPAX LABS INC
>>>活性成分:MORPHINE SULFATE; 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL; 规格:80MG; 治疗等效代码:AB<<<
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
202104 006 ANDA MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 80MG Prescription No No AB 2013/06/03 UPSHER SMITH LABS
200411 005 ANDA MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 80MG Discontinued No No AB 2016/04/12 IMPAX LABS INC
>>>活性成分:MORPHINE SULFATE; 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL; 规格:100MG; 治疗等效代码:AB<<<
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
202104 007 ANDA MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 100MG Prescription No Yes AB 2013/06/03 UPSHER SMITH LABS
200411 006 ANDA MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 100MG Discontinued No No AB 2016/04/12 IMPAX LABS INC
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2025 DrugFuture->U.S. FDA Drugs Database